InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer
REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVenn Biosciences, a company in the life sciences and technology sector, is pleased to announce that the…